background tiotropium inhaled anticholinergic maintenance treatment demonstrated effectiveness chronic obstructive pulmonary disease copd objective compare persistence inhaled respiratory drugs copd current clinical practice methods pharmo database includes hospital discharge records NUMBER million subjects netherlands probable identified new respiratory drug use age NUMBER years new users tiotropium ipratropium betaagonists labas fixed combination laba inhaled corticosteroids labaics included study persistence assessed quarterly year patients proportion days covered pdc NUMBER considered persistent persistence analysed using generalised estimating equations model results NUMBER new users tiotropium continued treatment NUMBER year compared NUMBER ipratropium NUMBER laba NUMBER labaics multivariate analyses showed times persistent therapy patients using ipratropium relative risk rr NUMBER NUMBER confidence interval ci laba rr NUMBER NUMBER ci labaics rr NUMBER NUMBER ci respectively patients prior hospitalisation copd showed persistence rates increased treatments varying NUMBER patients using labaics NUMBER patients using tiotropium persistence tiotropium times higher compared treatments conclusion persistence tiotropium higher compared inhaled respiratory drugs copd clinical practice daily tiotropium use drug dispensing copd patients copd hospitalisations long acting NUMBER NUMBER follow tiotropium users NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER sub analyses NUMBER year NUMBER NUMBER